What is the estimated glomerular filtration rate (eGFR) for a 51-year-old male with a serum creatinine of 1.60 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

eGFR Calculation for 51-Year-Old Male with Creatinine 1.60 mg/dL

For a 51-year-old male with serum creatinine of 1.60 mg/dL, the estimated glomerular filtration rate (eGFR) is approximately 48-52 mL/min/1.73 m², placing him in CKD Stage 3a, which requires clinical evaluation and management.

Calculation Method

The CKD-EPI equation without race (CKD-EPIcr 2021) is the current standard for eGFR calculation 1. This equation was adopted after the 2021 NKF-ASN Task Force recommendation to remove race from GFR estimation 1.

Using CKD-EPI 2021 Equation:

  • Age: 51 years
  • Sex: Male
  • Serum Creatinine: 1.60 mg/dL

The calculated eGFR is approximately 50 mL/min/1.73 m² 1, 2.

Clinical Significance

This patient has Stage 3a CKD (eGFR 45-59 mL/min/1.73 m²), representing moderate reduction in kidney function 3, 4. At this level:

  • He has lost approximately 50-60% of normal kidney function for his age 4
  • Normal GFR for a young adult male is approximately 125-130 mL/min/1.73 m² 3
  • Age-related decline accounts for some reduction, but eGFR <60 mL/min/1.73 m² at age 51 is abnormal 4

Required Clinical Actions

Immediate evaluation needed 5, 3:

  • Measure urine albumin-to-creatinine ratio (UACR) to assess for kidney damage 3
  • Screen for CKD complications: anemia, bone mineral disease, electrolyte abnormalities 6
  • Assess cardiovascular risk factors: blood pressure, lipids, diabetes 6
  • Review medications for nephrotoxic agents and adjust dosing for reduced GFR 7

Consider nephrology referral if 7:

  • eGFR continues to decline
  • Significant proteinuria present (UACR ≥300 mg/g)
  • Progressive decline toward eGFR <45 mL/min/1.73 m²

Important Caveats

Equation Limitations

The CKD-EPI creatinine equation has inherent imprecision 2, 8. The actual GFR could range ±30% from the estimated value in approximately 90% of cases 2. For this patient, true GFR might be anywhere from 35-65 mL/min/1.73 m².

When to Consider Cystatin C

Add cystatin C measurement if 1, 2:

  • Clinical decisions require greater precision (e.g., chemotherapy dosing, potential kidney donation evaluation)
  • eGFR is near critical thresholds (45-59 mL/min/1.73 m²)
  • Creatinine-based estimate seems inconsistent with clinical picture

The combined creatinine-cystatin C equation (CKD-EPI cr-cys) provides superior accuracy, correctly reclassifying 16.9% of patients with eGFRcr 45-59 mL/min/1.73 m² 2.

Factors Affecting Creatinine-Based eGFR

This estimate may be inaccurate if the patient has 9, 8:

  • Extremes of muscle mass (bodybuilders, amputees, severe malnutrition)
  • Recent changes in muscle mass or dietary protein intake
  • Acute kidney injury (non-steady state creatinine)
  • Severe liver disease (reduced creatinine production)

Race Consideration

The 2021 equation removed the race coefficient that previously increased eGFR estimates for Black individuals by approximately 16% 1. This change reduces differential bias but may slightly underestimate GFR in some Black patients while overestimating in some non-Black patients 1.

Monitoring Strategy

For Stage 3a CKD 5, 3:

  • Repeat eGFR and UACR at least annually
  • More frequent monitoring (every 3-6 months) if progressive decline or significant proteinuria
  • Implement blood pressure control (target <130/80 mmHg if proteinuric) 6
  • Consider ACE inhibitor or ARB if hypertensive with albuminuria 5

References

Guideline

standards of medical care for type 2 diabetes in china 2019.

Diabetes/Metabolism Research and Reviews, 2019

Research

Estimating glomerular filtration rate with new equations: can one size ever fit all?

Critical reviews in clinical laboratory sciences, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.